PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 118 filers reported holding PROVENTION BIO INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,388,431 | +354.6% | 99,105 | +99.4% | 0.00% | – |
| Q4 2022 | $525,393 | +73.4% | 49,706 | -26.0% | 0.00% | – |
| Q3 2022 | $303,000 | +1.7% | 67,177 | -10.0% | 0.00% | – |
| Q2 2022 | $298,000 | -23.2% | 74,661 | +41.1% | 0.00% | – |
| Q1 2022 | $388,000 | -32.9% | 52,900 | -48.6% | 0.00% | – |
| Q4 2021 | $578,000 | +125.8% | 102,826 | +156.4% | 0.00% | – |
| Q3 2021 | $256,000 | -18.2% | 40,101 | +7.8% | 0.00% | – |
| Q2 2021 | $313,000 | -34.7% | 37,203 | -18.6% | 0.00% | – |
| Q1 2021 | $479,000 | +3.7% | 45,721 | +67.5% | 0.00% | – |
| Q4 2020 | $462,000 | -19.1% | 27,303 | -38.6% | 0.00% | – |
| Q3 2020 | $571,000 | -34.9% | 44,488 | -28.5% | 0.00% | – |
| Q2 2020 | $877,000 | +256.5% | 62,223 | +133.0% | 0.00% | – |
| Q1 2020 | $246,000 | +134.3% | 26,702 | +281.5% | 0.00% | – |
| Q4 2019 | $105,000 | +183.8% | 7,000 | +28.0% | 0.00% | – |
| Q3 2019 | $37,000 | +640.0% | 5,468 | +1186.6% | 0.00% | – |
| Q2 2019 | $5,000 | +400.0% | 425 | -42.5% | 0.00% | – |
| Q4 2018 | $1,000 | – | 739 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 217,050 | $2,278,000 | 1.60% |
| Perceptive Advisors | 2,852,058 | $29,932,000 | 0.38% |
| 683 Capital Management, LLC | 630,000 | $6,612,000 | 0.35% |
| ADVISORY RESEARCH INC | 237,500 | $2,493,000 | 0.18% |
| GILDER GAGNON HOWE & CO LLC | 3,109,874 | $32,638,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,195 | $2,594,000 | 0.08% |
| Virtus ETF Advisers LLC | 16,158 | $170,000 | 0.07% |
| Walleye Capital LLC | 103,823 | $1,090,000 | 0.06% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 22,755 | $239,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 29,384 | $308,000 | 0.05% |